Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | SCN1A | P35498 | 1/20 | 0.32 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.32 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10186400 | 0.82 | CYP19A1 (0.46) | CYP19A1SCN1ASCN2ASCN3ATSHR | |
| SCHEMBL10186398 | 0.81 | CYP17A1 (0.43) | CYP19A1MEN1KMT2A | |
| SCHEMBL98386 | 0.81 | CYP19A1 (0.39) | CYP19A1MEN1KMT2A | |
| SCHEMBL10186406 | 0.78 | NPSR1 (0.44) | S1PR1MEN1KMT2AGAAKDM4E | |
| SCHEMBL12997501 | 0.73 | CYP19A1 (0.42) | CYP19A1TSHRMEN1KMT2ATDP1 | |
| Hydrochloric Acid SCHEMBL31564947 | 0.72 | CYP19A1 (0.44) | CYP19A1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL12997503 | 0.72 | CYP19A1 (0.44) | CYP19A1MEN1KMT2AGAATDP1 | |
| SCHEMBL11920840 | 0.70 | SMN1; SMN2 (0.34) | TSHRMEN1KMT2ATDP1POLB | |
| SCHEMBL98384 | 0.69 | THRB (0.35) | MEN1KMT2APOLBAPOBEC3AAPOBEC3G | |
| Hydrochloric Acid SCHEMBL31564979 | 0.69 | CYP19A1 (0.40) | CYP19A1SCN1ASCN2ASCN3ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120015299-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR | TOKYO OHKA KOGYO CO., LTD. (JP) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015299-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR | RER1, ASIC1, ABCC1 | CYP19A1 138/4885SCN1A 412/4885SCN2A 960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.